Aganepag inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins.
Molecular Weight
429.57
Molecular Formula
C24H31NO4S
Form
Lyophilized powder
Purity
>98%
Applications
Aganepag can be used to research and develop therapeutic strategies for certain diseases that involve excessive activation of GPCR-G protein signaling pathways.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
